MedTech News
.................... by Andrew Celentano
AI tool reveals what attracts immune cells to tumors and what keeps them away
Researchers at The University of Texas MD Anderson Cancer Center and collaborating institutions in Texas developed an artificial intelligence (AI) model that helps explain how immune cells find their way to specific locations in the body and why they avoid others. The findings could help scientists better understand cancer, autoimmune diseases and treatment response.
Emotion-focused AI spots early signs of psychosis in youths from short speech samples
Nanyang Technological University, Singapore (NTU Singapore) and the Institute of Mental Health (IMH) have developed an artificial intelligence (AI) framework capable of identifying youths at high risk of psychosis from short samples of casual, spontaneous speech.
Continuously evolving cells help pancreatic cancer evade treatment and spread
An analysis of nearly half a million cells from dozens of patients’ tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.
One dose of protein-targeting CAR-T cells shrinks solid tumors in preclinical tests
CAR-T cell therapies have fundamentally transformed the treatment of several blood and lymph node cancers.
Two studies link elevated ear protein levels in blood to tinnitus
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.
Blink-powered glasses could keep an eye on health
The ultra-low-power design could pave the way for smart glasses that continuously monitor health without constant charging.
FDA grants 510(k) clearance for Urolution Medical’s OpenFlo catheter
Urolution Medical is preparing comparative clinical trials to evaluate catheter performance and patient outcomes.
Experiments reveal how DNA-packaging protein mutation promotes breast cancer spread
A research team led by professor Chan Kui-ming from the Department of Biomedical Sciences at CityUHK discovered that H2BE113K, a missense H2B mutation, promotes colony formation and lung metastasis in breast cancer.